The linear gadolinium-based contrast agent (GBCA) gadodiamide accumulates in the brain early in the course of multiple sclerosis (MS), but has no apparent clinical or radiologic impact, results of a ...
Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results